Abstract:OBJECTIVES:To examine p53 codon 72 polymorphism in cervical cancers and its correlation with HPV16/18 E6.METHODS:Cervical specimens were taken from 81 patients with cervical squamous cancer, 18 patients with cervical adenocarcinoma, 88 patients with CIN II - III and 60 patients without cancers. PCR was used to examine the p53 genotypes and the expression of HPV16 and 18 E6.RESULTS:The frequencies of p53 Arg homozygosity in cervical squamous cancer, cervical adenocarcinoma and CIN (II - III) were 58.020%, 55.55% and 59.09% respectively, greater than those of p53 Arg/Pro heterozygosity (30.86%, 27.78%, 21.59%) and those of p53 Pro homozygosity (11.12%, 16.67%, 19.32%). The normal cervical samples also showed less frequency of p53 Arg homozygosity (23.33%) than cervical squamous cancer. There were no significant differences in the frequencies of p53 Arg homozygosity, p53 Arg/Pro heterozygosity and p53 Pro homozygosity (23.33%, 40.00% and 36.67% respectively). The frequency of HPV16,18 E6-positive in cervical cancer and CIN was much higher than that in control group (81.84%, 50.00% and 53.41%) for the normal cervical samples. The expression of HPV16 and 18 E6 in cervical squamous cancers was more frequent than in CIN. The frequency of p53 Arg homozygosity in HRHPV E6-positive cervical squamous cancers (64.06%) was greater than in HRHPV E6-negative cervical squamous cancers (35.29%) and in HRHPV E6-positive normal samples (33.33%). The p53 codon 72 polymorphism showed no differences in samples with different FIGO staging and grades.CONCLUSION:p53 Arg homozygosity could serve as a risk indicator for the tumorigenesis of cervix. In combination with HRHPV E6, it might be able to predict the progression of cervical lesions. p53 codon 72 polymorphism is not associated with FIGO staging and grades of cervical cancers.

Relationship between p67, p73 and head and neck tumors

[Alteration of P73 and P51 Genes and Its Significance in Human Gastric Carcinogenesis]

Progress in Investigation on P73 Gene and Human Tumorigenesis

P032 Differential Protein Expression Patterns of P53, NF-κB, and NF-κB– Regulated Genes in Head and Neck Squamous Cell Carcinoma

Relationship Between P21,p53 Expression and Single Nucleotide Polymorphism with Hepatocellular Carcinoma

The Biological Characteristics of P73 in Hematological Malignancies

Expression and Clinical Significance of P73 Gene in Colon Carcinoma

P63 in health and cancer

[Human Papillomavirus, Human Cytomegalovirus and P53 Gene in Cervical Carcinoma].

P73、P51基因在乳腺癌组织中mRNA的表达及意义

NAMPT Inhibitor and P73 Activator Represses P53 R175H Mutated HNSCC Cell Proliferation in a Synergistic Manner

P53 Codon 72 Polymorphism in Cervical Cancers and Its Correlation with HPV16,18E6

Expression of P73,P16 in cervical carcinoma and cervical intraepithelial neoplasm

P73 Overexpression and Angiogenesis in Human Colorectal Carcinoma

The structure and function of p63 gene

Relationship Between Polymorphism of P53 Gene and Susceptivity of Lung Cancer

Expression of p73 gene in human non-small cell lung cancer i n vitro

The Relationship Between P53 Gene Mutations and Clinicopathological Features in Glioma

Significance of overexpressions of p53 homologues p73 and p63 in pancreatic adenocacinoma

Down-Regulation of P73 Correlates with High Histological Grade in Japanese with Breast Carcinomas

Epigenetic modification in the expression of p73 p73 - epigenetic target for anticancer therapy